H-Index
10
Scimago Lab
powered by Scopus
eISSN: 2325-4416
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
AmJCaseRep

Annals
ISI-Home

TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

Fang Zhou, Meng Wang, Mijiti Aibaidula, Zhiguo Zhang, Abudusaimaiti Aihemaiti, Rezhake Aili, Hao Chen, Shuangfeng Dong, Wei Wei, Abulizi Maimaitiaili

Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China (mainland)

Med Sci Monit 2020; 26:e925147

DOI: 10.12659/MSM.925147

Available online: 2020-06-08

Published: 2020-08-04


BACKGROUND: Metastasis contributes to the high mortality rate of non-small cell lung cancer (NSCLC), and gaining a better understanding of its metastatic mechanisms would aid in initiating effective clinical treatment.
MATERIAL AND METHODS: In this study, bioinformatics analyses of the GEO database and TCGA-LUAD were first used to identify the key node gene regulating NSCLC malignant progression. Further in vitro experiments, including wound healing assay, invasion assay, Western blot assay, and luciferase report assay, were used to clarify the functions and mechanism of TPX2 in NSCLC.
RESULTS: Results of the TCGA analysis showed that TPX2 was significantly positively correlated with tumor metastasis and growth and the clinical stage of NSCLC. In addition, high levels of TPX2 significantly indicated a poor survival rate. In vitro experimental results also revealed that the upregulation of TPX2 significantly promoted NSCLC cell migration and invasion and could affect cell replasticity. Further results indicated that TPX2 significantly activated the epithelial-mesenchymal transition process and promoted the expression and activities of matrix metalloproteinase (MMP)2 and MMP9.
CONCLUSIONS: This study demonstrated that TPX2 promotes the metastasis and malignant progression of NSCLC and could thus serve as a marker of poor prognosis in NSCLC.

Keywords: Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis



Back